Liminatus Pharma, Inc. Class A Common Stock

LIMN

Healthcare|Biotechnology|US

$2.54

-0.09 (-3.42%)

Tangible Book / Share

$0.63

Cash / Share

$6.35

Clinical Trials (0)

Trial	Conditions	Phase	Status	Enrollment	Design	Drug